MTOR and prostate carcinoma: GAS5 is a member of the 5′‐terminal oligopyrimidine tract (5′‐TOP) family that is controlled by mTOR and has been shown to be upregulated by rapamycin (an mTOR inhibitor) in prostate cancer and T cells 33, 34.